Neoplasm syndromes, also known as tumor predisposition syndromes, are genetic disorders that increase an individual's risk of developing benign or malignant tumors due to inherited mutations in specific genes. These syndromes often involve multiple organ systems and require vigilant monitoring and management to mitigate cancer risk and improve patient outcomes.